Rani Therapeutics Holdings annual current ratio
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Current Ratio Growth & History (RANI)
Rani Therapeutics Holdings's current ratio was 4.21 for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.21 | 2.71 | +181.46% |
| 2024 | 2024-12-31 | 1.50 | −4.87 | −76.51% |
| 2023 | 2023-12-31 | 6.36 | −14.60 | −69.63% |
| 2022 | 2022-12-31 | 20.96 | −24.34 | −53.73% |
| 2021 | 2021-12-31 | 45.30 | 31.18 | +220.85% |
| 2020 | 2020-12-31 | 14.12 | — | — |
Rani Therapeutics Holdings quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.31 | 4.78 | +889.58% |
| Q1 2026 | 2026-03-31 | 3.40 | 2.52 | +284.74% |
| Q4 2025 | 2025-12-31 | 4.21 | 2.71 | +181.46% |
| Q3 2025 | 2025-09-30 | 0.26 | −1.34 | −83.84% |
| Q2 2025 | 2025-06-30 | 0.54 | −1.40 | −72.21% |
| Q1 2025 | 2025-03-31 | 0.88 | −2.21 | −71.45% |
| Q4 2024 | 2024-12-31 | 1.50 | −4.87 | −76.51% |
| Q3 2024 | 2024-09-30 | 1.60 | −7.01 | −81.39% |
| Q2 2024 | 2024-06-30 | 1.93 | −11.39 | −85.49% |
| Q1 2024 | 2024-03-31 | 3.09 | −14.19 | −82.10% |
| Q4 2023 | 2023-12-31 | 6.36 | −14.60 | −69.63% |
| Q3 2023 | 2023-09-30 | 8.61 | −5.41 | −38.59% |
| Q2 2023 | 2023-06-30 | 13.32 | −5.00 | −27.31% |
| Q1 2023 | 2023-03-31 | 17.29 | −9.00 | −34.24% |
| Q4 2022 | 2022-12-31 | 20.96 | −24.34 | −53.73% |
| Q3 2022 | 2022-09-30 | 14.02 | −11.20 | −44.41% |
| Q2 2022 | 2022-06-30 | 18.32 | 10.89 | +146.67% |
| Q1 2022 | 2022-03-31 | 26.29 | — | — |
| Q4 2021 | 2021-12-31 | 45.30 | 31.18 | +220.85% |
| Q3 2021 | 2021-09-30 | 25.21 | — | — |
| Q2 2021 | 2021-06-30 | 7.43 | — | — |
| Q4 2020 | 2020-12-31 | 14.12 | — | — |
Rani Therapeutics Holdings current ratio trends
Over the last five fiscal years, Rani Therapeutics Holdings's current ratio decreased from 14.12 to 4.21, a change of −9.91. The latest reported quarter, Q2 2026, shows 5.31.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗